IE47638B1 - Preparation of 4-methyl-5-chloromethyl-imidazole - Google Patents
Preparation of 4-methyl-5-chloromethyl-imidazoleInfo
- Publication number
- IE47638B1 IE47638B1 IE2565/78A IE256578A IE47638B1 IE 47638 B1 IE47638 B1 IE 47638B1 IE 2565/78 A IE2565/78 A IE 2565/78A IE 256578 A IE256578 A IE 256578A IE 47638 B1 IE47638 B1 IE 47638B1
- Authority
- IE
- Ireland
- Prior art keywords
- methyl
- hydrochloride
- imidazole
- reaction
- parts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Abstract
4-Methyl-5-chloromethyl-imidazole is prepared in the form of its hydrochloride by direct chloromethylation of 4-methyl-imidazole, thus becoming readily available industrially as an intermediate.
[US4211875A]
Description
PREPARATION OF 4-METHyL-5-CHL0R0METHYL-IIiIDAZ0L2
The present invention relates to a process for the preparation of 4-methyl-5-chloromethyl-imidazole, in the form of its hydrochloride, by chloromethylation of 4-methylimidazole.
4-Methyl-5-chloromethyl-imidazole hydrochloride has hitherto been prepared from 4-methyl-5-hydroxymethylimidazole by reaction with inorganic acid halides, as described by A.J. Ewins in J. Chem. Soc. 99 (1911), 2052-2059 or G.J. Durant et al. in J. Med. Chem. 19 (1976), 923-928.
It is a disadvantage of these processes that 4-methyl-5hydroxymethyl-imidazole must be used as a starting material, since this compound can only be prepared by relatively difficult and involved methods. For example, 4-methyl-5hydroxymethyl-imidazole has hitherto been prepared from 4methyl-imidazole-5-carboxylic acid esters by reduction with an alkali metal or with calcium, in liquid ammonia. This process is lengthy, expensive, and relatively difficult to carry out on an industrial scale because of the quantities of alkali metal in liquid ammonia which have to be handled; the process is described in German Laid-Open Application DOS 2,637,670.
We have found that 4-methyl-5-chloromethyl-imidazole hydrochloride can be prepared simply, on an industrial scale, by reacting 4-methylimidazole, in aqueous solution, with formaldehyde or a formaldehyde oligomer, in the presence of an excess cf hydrogen chloride, at from 25 to l60°C.
- 2 47638
The following equation illustrates the invention:
or o'^O or (H2C0)
+ 2 HCl·-* 7=\
N. N-H.
HCl
In the process according to the invention, the 4methylimidazole is advantageously dissolved in aqueous con5 centrated hydrochloric acid; as a rule the solutions prepared are of 10 - 25% strength by weight.
The formaldehyde can be used as a conventional aqueous solution, containing 15 - 40% by weight of formaldehyde, as a gas or as one of its solid oligomers, eg. para10 formaldehyde or 1,5,5-trioxane. The molar ratio of 4methylimidazole to formaldehyde is advantageously from 1:1 to 1:1.5,these ratios relating to the monomer, even if formaldehyde oligomers are used.
The hydrogen chloride is used in excess, advan15 tageously in the form of aqueous concentrated hydrochloric acid containing from 20 to 40% by weight of hydrogen chloride, or in the form of hydrogen chloride gas. Preferably, the reaction is carried out in a system containing both aqueous concentrated hydrochloric acid and hydrogen chloride gas. Hence, if the chloromethylation reaction is carried out under atmospheric pressure, it is advantageous to pass HCl gas through the reaction mixture, whilst if the reaction is carried out under pressure in a closed system, for example in an autoclave or a kettle, HCl gas can 25 be additionally introduced, up to a pressure of 10 atmospheres .
- 3 47638
The chloromethylation reaction according to the invention is carried out at from 25 to l6o°C, preferably from 50 to 110°C. When working with a closed system, the pressure set up is the autogenous pressure corresponding- to the particular temperature used.
The reaction is as a rule complete within a period of from 5 to 20 hours, depending on the temperature used.
The progress of the reaction can be followed spectroscopically, for example by NMR spectroscopy; · in the latter case, samples are taken from the reaction mixture and evaporated in the presence of concentrated DC1 (in D^O), after which the residue is analyzed.
The reaction product is worked up in the conventional manner, for example by distilling off the solvent and recrystallizing the residue, for example from a lower alcohol, eg. ethanol. To achieve a better yield, it is advantageous to use a solvent containing hydrogen chloride.
The starting compound, ie. 4-methylimidazole, can be used in the pure form or as a technical-grade product.
It is surprising that the process according to the invention, ie. direct chloromethylation of an imidazole in the 5-position, should proceed by means of a smooth reaction which can be carried out on an industrial scale without interfering side-reactions. Such a simple chloromethylation reaction was unexpected since it is known that in reactions in a strongly acid medium imidazole is deactivated by protonization. The high
- 4 47638 selectivity with which the chloromethyl group is introduced into the 5-position, without interfering substitution in the 1- or 2-position, was also unexpected since, for example, the nitrogen atom in the 1-position carries a ' hydrogen which normally is' easily replaceable. It is a further advantage that no interfering side-reactions of the resulting 5-chloromethyl compound, for example linking of imidazole rings via CHg groups, eg. the formation of diimidazolylmethane or of more highly condensed products, are observed, ,
The invention for the first time makes 4-methyl-5chloromethylimidazole,an important intermediate for further imidazole derivatives, easily obtainable industrially.
4-Methyl-5-chloromethyl-imidazole makes it possible 15 to obtain 4-methyl-5-hydroxymethyl-imidazole, or corresponding 5-alkoxymethyl derivatives, by advantageous methods, and these compounds can be used as intermediates, for example for the preparation of the drug cimetidine (N-cyanoN’-methyl-N-[2-((4-methyl-5-imidazolyl)-methylmercapto)2C ethyl]-guanidine), as described in German Laid-Open Applications DOS 2,544,779 and DOS 2,649,059.
4-Methyl-5-chloromethyliinidazole can also itself be used as an intermediate for the preparation of cimetidine, by reacting the compound with oysteamine hydrochloride in boiling concentrated hydrochloric acid, or reacting it directly with cysteamine hydrochloride in the absence of a solvent.
It is interesting that direct chloromethylation reactions of imidazoles have not previously been disclosed.
- 5 47638
Furthermore, for example, the related compound 3,5dimethyl-pyrazole, having one free NH group, cannot be caused to undergo a reaction which in the main results in chloromethylation at the carbon in the 4-position, since at room temperature the predominant reaction is substitution at the nitrogen whilst at elevated temperatures polymerization reactions occur, as described by J. Dvoretzky and J. Richter in J. Org. Chem. lg (1950), 1285-1288.
- The 4-methyl-5-chloromethylimidazole prepared 10 according to the invention can easily be converted to the corresponding 5-alkoxy compounds, whilst according to the prior art, for example, the preparation of 4-methyl-5alkoxymethyl-imidazoles is a complicated procedure starting from β-acetyl-vinyl-phosphonium halide, which is cyclized to 4-methyl-5-methyl-triphenylphosphonium-imidazole halide, the latter then being reacted with an alcohol/alcoholate mixture, as shown in the equation below (cf. German LaidOpen Application DOS 2,649,059):
ch3-co-ch=ch-p(c0h5)3 Halc
HN=CH-NH,
H„C ΟΗ,-ΡίΟ-.Ης), 2 6 5 3
N. N-H Hal® kz
ROH/RONa
--> CH, CH--OR
H N-H X
According to K. Wegner and W. Schunack, Arch.
Pharm. 310 (1977), 380-385, 4-methyl-5-methoxymethylimidazole may be prepared by methoxymercuration of methyl vinyl ketone, which is a very toxic compound.
- 6 47638
Br?
CH -CO-CH=CK2 + (CH_CO2)2Hg + CH^OH-4 CE^CO-CH-C^·©^— 5 J He-O2CCH5
HN=CH-NH,
CH -CO-CEBr-CH2-OCH3 -H-^- ^CHg-OCH^ rn
VK
This process is unsuitable for industrial operation, especially because of the formation of mercury salts and because it entails working in liquid ammonia.
The Examples which follow illustrate the process according to the invention without implying any limitations. EXAMPLE 1
218 parts of 37% strength formaldehyde solution are added dropwise, in the course of 4 hours, to a solution, at 80°C, of 167 parts of technical-grade 92.6% pure 4-methylimidazole in 826 parts of aqueous concentrated hydrochloric acid of about 36% strength by weight; at the same time a stream of HCI gas is passed into the mixture at the rate of about 65 parts by weight per hour, corresponding to 40,000 parts by volume per hour. The mixture is then heated for 20 hours at 80°C, whilst continuing to introduce HCI gas.
After completion of the reaction, the aqueous hydrochloric acid is substantially distilled off under reduced pressure from a waterpump. 700 parts of a solution of HCI gas in ethanol (j7 = 0.88) are added to the residue and the mixture is heated to the boil. It is then cooled to about +5°C and the precipitate formed is filtered off, washed with a solution of HCI gas in ether, and dried under reduced pres25 sure. 197.5 parts of 4-methyl-5-chloromethyl-imidazole
- 7 7638 hydrochloride of melting point 213°C are obtained. A further 17.4 parts, of melting point 206°C, are obtained from the mother liquor and the ether wash solution, so that the total yield is 68.2%.
EXAMPLE 2
A mixture of 124 parts of aqueous concentrated hydrochloric acid of about 36% strength by weight, 25 parts of 92.6% pure 4-methylimidazole and 10.8 parts of paraformaldehyde is heated for 16 hours at 90°C in a closed glass-lined kettle. The hydrochloric acid is then substantially distilled off under reduced pressure from a waterpump and the residue is dissolved in 160 parts of a boiling solution of HCl gas in ethanol ( f = 0.88). After the mixture has cooled, the crystals which. have precipitated are filtered off, washed with a solution of-HCl gas in ethanol and a solution of HCl gas in ether, and dried under reduced pressure. 20 parts of product, of melting point 214 2l6°C, are obtained. A further 4.2 parts, of melting point 209 - 210°C, are obtained from the mother liquor and the wash solutions, so that the total yield is 51.3%.
EXAMPLES OF FURTHER CONVERSIONS OF 4-METHYL-5-CHL0R0METHYL-IMIDAZ0LE
I. 4-Methyl-5-ethoxymethyl-imidazole hydrochloride
2.0 parts of 4-methyl-5-chloromethyl-imidazole hydrochloride in 6.5 parts of absolute ethanol are boiled for 20 hours. The mixture is then evaporated almost to dryness and the resulting solid crystalline product is filtered dry on a fritted glass disk.
- 8 47638
1.9 parts (90%) of 4-methyl-5-ethoxymethyl-imidazole hydrochloride of melting point l4l-l43°C are obtained.
A further recrystallization from acetonitrile, to prepare analytically pure material, gives 1.6 parts (75%) of melting point 143°C.
Analysis: C H Cl ' N 0 calculated: 47.6 7.4 20.1 15.9 9.1 found: 47.3 7.2 20.7 16.1 9.1
II. 4-Methyl-5-hydroxymethyl-imidazole hydrochloride parts of 4-methyl-5-chloromethyl-imidazole hydrochloride are dissolved in 200 parts of water and the mixture is stirred for 4.5 hours at 50 - 60°C. The water is then substantially distilled off under reduced pressure from a waterpump and the crystal slurry is recrystallized from ethanol, the solution being cooled in ice. 43.4 parts (73%) of 4-methyl-5-hydroxymethyl-imidazole hydrochloride of melting point 238 - 240°C are obtained (the melting point given in the literature is 240 - 242°C, cf. A.J. Ewins, J. Chem. Soc. 99 (1911), 2052.
A further 6.7 parts (11%) of product, of melting point 236 - 239°, can be isolated by working up the mother liquor.
III. 4-Methyl-5-[(2-amino-ethyl)thiomethyl]-imidazole dihydrochioride
a) A solution of 50.1 parts of 4-methyl-5-chloromethylimidazole hydrochloride and 34.1 parts of cysteamine hydrochloride in 410 parts of aqueous 36% strength hydrochloric
- 9 • 47638 acid is boiled for 20 hours. The aqueous hydrochloric acid is then substantially distilled off under reduced pressure from a waterpump, and the pasty residue is dissolved in 80 parts of boiling ethanol. After cooling to room tem5 perature, filtering off the product and drying it, 56.5 parts (78%) of the dihydroehloride, of melting point 193 196°C, are obtained. A further 7.8 parts (11%) can be isolated by concentrating the filtrate; melting point 191 194°C.
b) 84 parts of 4-methyl-5-chloromethyl-imidazole hydrochloride, in the form of a fine powder, and 57 parts of eysteamine hydrochloride, also in the form of a fine powder, are mixed intimately and the mixture is heated in a solidstate reactor for 2 hours at 80° and then for 7 hours at
100°; the progress of the reaction can be followed by NMR spectroscopy or from the evolution of hydrogen chloride.
120 parts (98%) of 4-met’hyl-5-[(2-amino-ethyl)-thiomethyl]imidazole dihydroehloride are obtained; the substance melts at 186 - 189°C, after first sintering at about 181°C.
A single recrystallization of the product from ethanol raises the melting point to 193 - 195^0.
- 10 47638
Claims (7)
1. CLAIMS:1. A process for the preparation of 4-methyl-5-chloroi methylimidazole hydrochloride, wherein 4-methylimidazole, in aqueous solution, is reacted with formaldehyde or a 5 formaldehyde oligomer in the presence of an excess of hydrogen chloride, at from 25 to l6o°C.
2. A process as claimed in claim 1, wherein the reaction is carried out in aqueous hydrochloric acid, whilst at the same time passing gaseous hydrogen chloride through the 1° mixture, and using a molar ratio of 4-methylimidazole to formaldehyde of from 1:1 to 1:1.5.
3. A process as claimed in claim 1, wherein the reaction is carried out in a closed system under pressure.
4. A process for the preparation of 4-methyl-5~chloro15 methyl-imidazole hydrochloride carried out substantially as described in either of the foregoing Examples 1 and 2.
5. 4-Methy1-5-chloromethylimidazole hydrochloride when prepared by a process as claimed in any of claims 1 to 4,
6. 4-Methyl-5-hydroxymethylimidazolo and corresponding 20 5-alkoxymethyl compounds when obtained by hydrolysis or alcoholysis of 4-methy1-5-chloromethylimidazole hydrochloride prepared as claimed in any rf claims 1 to 4.
7. Cimetidine when obtained from 4-methyl-5-chloromethyl hydrochloride prepared as any of to 4 imidazole/claimed ir/ claims 1/by reaction with cysteamine 25 hydrochloride in boiling concentrated hydrochloric acid or by known methods in the absence of a solvent and when obtained/from 4-methyl5-hydroxymethylimidaaole prepared in accordancewith Claim 6.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782800148 DE2800148A1 (en) | 1978-01-03 | 1978-01-03 | PROCESS FOR THE PRODUCTION OF 4-METHYL-5-CHLOROMETHYL-IMIDAZOLE |
Publications (2)
Publication Number | Publication Date |
---|---|
IE782565L IE782565L (en) | 1979-07-03 |
IE47638B1 true IE47638B1 (en) | 1984-05-16 |
Family
ID=6028908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2565/78A IE47638B1 (en) | 1978-01-03 | 1978-12-28 | Preparation of 4-methyl-5-chloromethyl-imidazole |
Country Status (6)
Country | Link |
---|---|
US (1) | US4211875A (en) |
EP (1) | EP0003052B1 (en) |
JP (1) | JPS54100372A (en) |
CA (1) | CA1107743A (en) |
DE (2) | DE2800148A1 (en) |
IE (1) | IE47638B1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2908212A1 (en) * | 1979-03-02 | 1980-09-11 | Basf Ag | METHOD FOR PRODUCING 5-HYDROXYMETHYLIMIDAZOLES |
JPH01272570A (en) * | 1988-04-26 | 1989-10-31 | Nippon Shokubai Kagaku Kogyo Co Ltd | Production of 4-methyl-5-((2-aminoethyl)-thiomethyl)-imidazole |
JPH0611264U (en) * | 1991-12-02 | 1994-02-10 | 中央防雷株式会社 | Electrode rod joint |
US5965717A (en) * | 1997-11-04 | 1999-10-12 | North Carolina State University | Organic pigments from twisted benzidines |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1397436A (en) | 1972-09-05 | 1975-06-11 | Smith Kline French Lab | Heterocyclic n-cyanoguinidines |
PT65369B (en) | 1975-08-20 | 1978-01-10 | Smithkline Corp | Reduction process |
GB1570212A (en) | 1975-10-29 | 1980-06-25 | Smithkline Corp | Imidazoles |
US4104473A (en) * | 1976-04-23 | 1978-08-01 | Shikoku Chemicals Corporation | Novel imidazole compounds and process for preparations thereof |
-
1978
- 1978-01-03 DE DE19782800148 patent/DE2800148A1/en not_active Withdrawn
- 1978-12-27 CA CA318,628A patent/CA1107743A/en not_active Expired
- 1978-12-27 JP JP16028878A patent/JPS54100372A/en active Granted
- 1978-12-28 IE IE2565/78A patent/IE47638B1/en not_active IP Right Cessation
- 1978-12-28 DE DE7878101858T patent/DE2860555D1/en not_active Expired
- 1978-12-28 EP EP78101858A patent/EP0003052B1/en not_active Expired
- 1978-12-29 US US05/974,248 patent/US4211875A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS6138188B2 (en) | 1986-08-28 |
EP0003052B1 (en) | 1981-03-18 |
DE2860555D1 (en) | 1981-04-16 |
EP0003052A3 (en) | 1979-08-22 |
JPS54100372A (en) | 1979-08-08 |
US4211875A (en) | 1980-07-08 |
IE782565L (en) | 1979-07-03 |
CA1107743A (en) | 1981-08-25 |
EP0003052A2 (en) | 1979-07-25 |
DE2800148A1 (en) | 1979-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6177575B1 (en) | Process for manufacture of imidazoles | |
KR20040012495A (en) | Process for the monomethylation of nitrogenous heterocycles | |
US4211875A (en) | Preparation of 4-methyl-5-chloromethyl-imidazole | |
Katritzky et al. | Benzotriazole-1-carboxamidinium tosylate: an alternative method for the conversion of amines to guanidines | |
US4189592A (en) | Preparation of 4-methyl-5-[(2-aminoethyl)-thiomethyl]-imidazole dihydrochloride | |
US10053420B2 (en) | Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine | |
CA1064940A (en) | Reduction process for the preparation of 4-(hydroxymethyl) imidazole compounds | |
US4063023A (en) | Process for preparing 4-(hydroxymethyl)imidazole compounds | |
CA1134839A (en) | Preparation of 5-hydroxymethylimidazoles | |
US4900826A (en) | Process for preparing N6,9-disubstituted adenine | |
US2564648A (en) | Hydantoin manufacture | |
US6197964B1 (en) | Method for the production of 2,6-dichloro-5-fluoronicotinonitrile and the chemical compound 3-cyano-2-hydroxy-5-fluoropyride-6-one-monosodium salt its tautomers | |
CA1336196C (en) | Process for the preparation of n-cyanoethanimidic acid esters | |
JPS603068B2 (en) | Method for producing N-substituted imidazole derivatives | |
JPS63104964A (en) | Prodrug derivative of cardiac stimulant 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1h-imidazol- 1-yl)benzoyl)-2h-imidazole-2-one | |
JPS63246370A (en) | Production of amine compound | |
JPS6160673A (en) | Preparation of guanidinothiazole derivative | |
JP2585283B2 (en) | Method for producing imidazole derivative | |
US6562970B1 (en) | Method for producing 4-chloro-6-hydroxypyrimidine | |
JPS6023651B2 (en) | Method for hydrolyzing paraphenylenediamine | |
JP3814943B2 (en) | Production method of dialkyl carbonate | |
JP3814944B2 (en) | Process for producing dialkyl carbonate | |
US2908727A (en) | Reaction of diazo compounds | |
US5840913A (en) | Process for preparing N-substituted pyrazoles | |
US6720456B2 (en) | Process for the preparation of 2,3-pentanedione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed |